Cargando…
P881: CDK7 CONTRIBUTES TO METABOLIC REPROGRAMMING IN MM CELLS THROUGH C-MYC MEDIATED TRANSCRIPTIONAL CONTROL OF GLYCOLYTIC GENES
Autores principales: | Yao, Y., Fong Ng, J., Park, W. D., Gramegna, D., Samur, A., Samur, M., Morelli, E., Chesi, M., Mitsiades, C., Anderson, K. C., Lin, C., Munshi, N., Fulciniti, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430844/ http://dx.doi.org/10.1097/01.HS9.0000846400.43498.af |
Ejemplares similares
-
CDK7 controls E2F- and MYC-driven proliferative and metabolic vulnerabilities in multiple myeloma
por: Yao, Yao, et al.
Publicado: (2023) -
miR-23b/SP1/c-myc forms a feed-forward loop supporting multiple myeloma cell growth
por: Fulciniti, M, et al.
Publicado: (2016) -
Deciphering the chronology of copy number alterations in Multiple Myeloma
por: Aktas Samur, Anil, et al.
Publicado: (2019) -
In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors
por: Aktas Samur, Anil, et al.
Publicado: (2022) -
Genome-Wide Somatic Alterations in Multiple Myeloma Reveal a Superior Outcome Group
por: Samur, Mehmet Kemal, et al.
Publicado: (2020)